Word

ZIXXIVUS

Status

Pending

Status Code

730

Status Date

Monday, June 17, 2024

Serial Number

98139376

Mark Type

4

Filing Date

Friday, August 18, 2023

Published for Opposition

Tuesday, December 19, 2023

Trademark Owner History

Vanda Pharmaceuticals Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the prevention of motion sickness; Pharmaceutical preparations for the prevention of social anxiety or performance anxiety; Pharmaceutical preparations for the treatment and prevention of craving; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of insomnia; Pharmaceutical preparations for the treatment and prevention of social anxiety or performance anxiety; Pharmaceutical preparations for the treatment of circadian rhythm diseases and disorders; Pharmaceutical preparations for the treatment of Non-24-Hour Sleep-Wake Disorder; Pharmaceutical preparations for the treatment of jet lag disorder; Pharmaceutical preparations for the treatment of Delayed Sleep Phase Disorder (DSPD); Pharmaceutical preparations for the treatment of bipolar disorder; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of motion sickness; Pharmaceutical preparations for the treatment of hematologic malignancies; Pharmaceutical preparations for the treatment of insomnia; Pharmaceutical preparations for the treatment of Autism Spectrum Disorder (ASD); Pharmaceutical preparations for the treatment of Parkinson's Disease Psychosis; Pharmaceutical preparations for the treatment of COVID-19 pneumonia; Pharmaceutical preparations for the treatment of social anxiety or performance anxiety; Pharmaceutical preparations for the treatment of Smith-Magenis Syndrome; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology

Trademark Events

Aug 22, 2023

New Application Entered

Sep 18, 2023

New Application Office Supplied Data Entered

Nov 13, 2023

Assigned To Examiner

Nov 29, 2023

Notification Of Notice Of Publication E-Mailed

Nov 16, 2023

Approved For Pub - Principal Register

Dec 19, 2023

Published For Opposition

Dec 19, 2023

Official Gazette Publication Confirmation E-Mailed

Feb 13, 2024

Noa E-Mailed - Sou Required From Applicant

Jun 17, 2024

Sou Teas Extension Received

Jun 17, 2024

Notice Of Approval Of Extension Request E-Mailed

Jun 17, 2024

Sou Extension 1 Filed

Jun 17, 2024

Sou Extension 1 Granted